Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Accenture
Covington
QuintilesIMS
Boehringer Ingelheim
McKinsey
Julphar
Argus Health
Baxter

Generated: November 16, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Gusperimus

« Back to Dashboard

US Patents for Gusperimus

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Gusperimus ➤ Sign Up Covalently-linked complexes and methods for enhanced cytotoxicity and imaging NeoRx Corporation (Seattle, WA) ➤ Sign Up
Gusperimus ➤ Sign Up Crystalline deoxyspergualin, process for its preparation and suppository containing the same Takaru Shuzo Co., Ltd. (Kyoto, JP) Nippon Kayaku Kabushiki Kaisha (Tokyo, JP) ➤ Sign Up
Gusperimus ➤ Sign Up Covalently-linked complexes and methods for enhanced cytotoxicity and imaging NeoRx Corporation (Seattle, WA) ➤ Sign Up
Gusperimus ➤ Sign Up Crystalline deoxyspergualin, process for its preparation and suppository containing the same Takara Shuzo Co., Ltd. (Kyoto, JP) ➤ Sign Up
Gusperimus ➤ Sign Up Imidazolidyl macrolides having immunosuppressive activity Merck & Co., Inc. (Rahway, NJ) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Gusperimus

Drugname Country Document Number Estimated Expiration Related US Patent
Gusperimus Austria 83669 2008-08-15 ➤ Sign Up
Gusperimus Canada 1334513 2008-08-15 ➤ Sign Up
Gusperimus Germany 68904019 2008-08-15 ➤ Sign Up
Gusperimus European Patent Office 0359347 2008-08-15 ➤ Sign Up
Gusperimus Japan H02124833 2008-08-15 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Accenture
Colorcon
Healthtrust
Covington
US Department of Justice
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.